AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12912818 — intervention group
Group type: EXPERIMENTAL
Intervention: Methionine-loading test (100 mg/kg body weight, administered orally)
Number of subjects: 23
Study 12912818 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation analysis
Number of subjects: 23
Study 10825325 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.08% bupivacaine plus 2 microg/mL fentanyl (BF)
Number of subjects: 40
Study 10825325 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.08% ropivacaine plus 2 microg/mL fentanyl (RF)
Number of subjects: 40
Study 8851898 — intervention group
Group type: COMPARATOR
Intervention: Ambulatory Control (AC)
Number of subjects: 6
Study 8851898 — intervention group
Group type: EXPERIMENTAL
Intervention: Water Immersion at 80 degrees (WI80)
Number of subjects: 6
Study 8851898 — intervention group
Group type: EXPERIMENTAL
Intervention: Water Immersion at 20 degrees (WI20)
Number of subjects: 6
Study 8851898 — intervention group
Group type: EXPERIMENTAL
Intervention: Chair Rest (CR)
Number of subjects: 6
Study 8851898 — intervention group
Group type: EXPERIMENTAL
Intervention: Head-Down Bed Rest (BR)
Number of subjects: 6
Study 7515429 — intervention group
Group type: EXPERIMENTAL
Intervention: 111In-CYT-103 immunoscintigraphy
Number of subjects: 10
Study 7515429 — intervention group
Group type: COMPARATOR
Intervention: Computed Tomography (CT)
Number of subjects: 10
Study 3311570 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute ethanol consumption
Number of subjects: 0
Study 29581659 — intervention group
Group type: EXPERIMENTAL
Intervention: Stabilization exercises with flexi-bar (FB)
Number of subjects: 27
Study 29581659 — intervention group
Group type: COMPARATOR
Intervention: Stabilization exercises (without FB)
Number of subjects: 27
Study 27072546 — intervention group
Group type: EXPERIMENTAL
Intervention: High G tolerance group (H group)
Number of subjects: 16
Study 27072546 — intervention group
Group type: COMPARATOR
Intervention: Low G tolerance group (L group)
Number of subjects: 16
Study 25351474 — intervention group
Group type: EXPERIMENTAL
Intervention: MEM 1414 (600 mg, twice daily orally for 7 days)
Number of subjects: 16
Study 25351474 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 22626489 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonverbal response-card method
Number of subjects: 0
Study 22626489 — intervention group
Group type: COMPARATOR
Intervention: Verbal responses (Control)
Number of subjects: 0
Study 20729674 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer mentoring strategy
Number of subjects: 0
Study 17906853 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone (HC) - intravenous bolus of 100 mg preceding a continuous infusion of 10 mg/h (n = 15)
Number of subjects: 30
Study 17906853 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 15)
Number of subjects: 30
Study 16425053 — intervention group
Group type: EXPERIMENTAL
Intervention: Disulfiram
Number of subjects: 0
Study 16425053 — intervention group
Group type: EXPERIMENTAL
Intervention: Active immunisation against cocaine dependence
Number of subjects: 0
Study 16425053 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate treatment in combination with cognitive behavioural therapy
Number of subjects: 0
Study 16425053 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigabatrin
Number of subjects: 0
Study 16425053 — intervention group
Group type: EXPERIMENTAL
Intervention: Selegiline
Number of subjects: 0
Study 16425053 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate
Number of subjects: 0
Study 12810429 — intervention group
Group type: EXPERIMENTAL
Intervention: Lymecycline
Number of subjects: 17
Study 12810429 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 11021677 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard Gamble
Number of subjects: 120
Study 11021677 — intervention group
Group type: EXPERIMENTAL
Intervention: Time Tradeoff
Number of subjects: 120
Study 11021677 — intervention group
Group type: EXPERIMENTAL
Intervention: Rating Scale
Number of subjects: 120
Study 11021677 — intervention group
Group type: EXPERIMENTAL
Intervention: Utility Techniques
Number of subjects: 120
Study 8799592 — intervention group
Group type: EXPERIMENTAL
Intervention: Prewarming by sitting for 30 min in a room at 30 degrees C
Number of subjects: 4
Study 8799592 — intervention group
Group type: COMPARATOR
Intervention: No prewarming (exercise in winter)
Number of subjects: 4
Study 8799592 — intervention group
Group type: EXPERIMENTAL
Intervention: Prewarming
Number of subjects: 4
Study 1511475 — intervention group
Group type: EXPERIMENTAL
Intervention: Fruits and vegetables (mean 582 g/day) for 12 weeks
Number of subjects: 406
Study 6217745 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 77
Study 6217745 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 77
Study 6217745 — intervention group
Group type: COMPARATOR
Intervention: Both groups (Acupuncture and Placebo)
Number of subjects: 77
Study 6217745 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial pain severity
Number of subjects: 77
Study 6217745 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychotropic drug intake
Number of subjects: 77
Study 29512356 — intervention group
Group type: EXPERIMENTAL
Intervention: M(3) program (Meals, Mindfulness, & Moving Forward)
Number of subjects: 33
Study 29512356 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 33
Study 29905977 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiromatic
Number of subjects: 29
Study 29905977 — intervention group
Group type: COMPARATOR
Intervention: Aerolizer
Number of subjects: 29
Study 29798016 — intervention group
Group type: EXPERIMENTAL
Intervention: Tympanostomy tube insertion with adenoidectomy
Number of subjects: 126
Study 29798016 — intervention group
Group type: COMPARATOR
Intervention: Tympanostomy tube insertion only (Control)
Number of subjects: 126
Study 25063905 — intervention group
Group type: EXPERIMENTAL
Intervention: OCP containing 30 mcg ethinyl estradiol (EE) plus 3 mg drospirenone for 3 months (Group 1)
Number of subjects: 200
Study 25063905 — intervention group
Group type: EXPERIMENTAL
Intervention: OCP containing 30 mcg ethinyl estradiol (EE) plus 3 mg drospirenone for 3 months (Group 3)
Number of subjects: 200
Study 25063905 — intervention group
Group type: COMPARATOR
Intervention: No medication (Group 2)
Number of subjects: 200
Study 25063905 — intervention group
Group type: COMPARATOR
Intervention: No medication (Group 4)
Number of subjects: 200
Study 22775126 — intervention group
Group type: EXPERIMENTAL
Intervention: Musical training in depressed participants
Number of subjects: 0
Study 22775126 — intervention group
Group type: COMPARATOR
Intervention: No musical training in depressed participants
Number of subjects: 0
Study 22775126 — intervention group
Group type: EXPERIMENTAL
Intervention: Musical training in non-depressed participants
Number of subjects: 0
Study 22775126 — intervention group
Group type: EXPERIMENTAL
Intervention: No musical training in non-depressed participants
Number of subjects: 0
Study 20619402 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleeve Gastrectomy (SG)
Number of subjects: 15
Study 20619402 — intervention group
Group type: COMPARATOR
Intervention: Roux-en-Y Gastric Bypass (RYGB)
Number of subjects: 15
Study 18372689 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily 1 hr short radius centrifugation
Number of subjects: 0
Study 18372689 — intervention group
Group type: COMPARATOR
Intervention: Control group (bed-rest without centrifugation)
Number of subjects: 0
Study 15727947 — intervention group
Group type: EXPERIMENTAL
Intervention: D2-ORFa-Gly3Asp polymorphism in blood donors
Number of subjects: 505
Study 15727947 — intervention group
Group type: EXPERIMENTAL
Intervention: D2-ORFa-Gly3Asp polymorphism in elderly men
Number of subjects: 505
Study 12011773 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium citrate (300 mg magnesium)
Number of subjects: 46
Study 12011773 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 9787979 — intervention group
Group type: EXPERIMENTAL
Intervention: Leukocyte interferon-alpha (1 MU three times weekly for one year)
Number of subjects: 10
Study 9787979 — intervention group
Group type: EXPERIMENTAL
Intervention: Leukocyte interferon-alpha (3 MU three times weekly for a second cycle)
Number of subjects: 10
Study 7667053 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.6 mg/kg/day iv, divided into 4 daily doses for 4 days)
Number of subjects: 56
Study 7667053 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 7667053 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 56
Study 2764271 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline injection, 4 mg/kg body weight
Number of subjects: 60
Study 2764271 — intervention group
Group type: COMPARATOR
Intervention: Control group (no theophylline)
Number of subjects: 60
Study 734381 — intervention group
Group type: EXPERIMENTAL
Intervention: Osmic acid
Number of subjects: 66
Study 734381 — intervention group
Group type: EXPERIMENTAL
Intervention: Radioactive yttrium
Number of subjects: 66
Study 734381 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical synovectomy
Number of subjects: 66
Study 31110103 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse care coordinator (NCC) led complex intervention
Number of subjects: 0
Study 31110103 — intervention group
Group type: EXPERIMENTAL
Intervention: NCC training
Number of subjects: 0
Study 31110103 — intervention group
Group type: EXPERIMENTAL
Intervention: Key process evaluation indicators
Number of subjects: 0
Study 28102199 — intervention group
Group type: EXPERIMENTAL
Intervention: Simo decoction and acupuncture
Number of subjects: 590
Study 28102199 — intervention group
Group type: COMPARATOR
Intervention: Chewing gum
Number of subjects: 590
Study 25617215 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic monitoring device with audiovisual reminders enabled
Number of subjects: 220
Study 25617215 — intervention group
Group type: COMPARATOR
Intervention: Control group (audiovisual reminders disabled)
Number of subjects: 220
Study 23261140 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam 0.25mg
Number of subjects: 34
Study 23261140 — intervention group
Group type: EXPERIMENTAL
Intervention: Buspirone 10mg
Number of subjects: 34
Study 23261140 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 22002264 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-incision laparoscopic cholecystectomy (SILC)
Number of subjects: 108
Study 22002264 — intervention group
Group type: COMPARATOR
Intervention: Conventional laparoscopic cholecystectomy (CLC)
Number of subjects: 108
Study 18641035 — intervention group
Group type: EXPERIMENTAL
Intervention: NRTI-sparing regimen (NNRTI + boosted protease inhibitor)
Number of subjects: 117
Study 18641035 — intervention group
Group type: COMPARATOR
Intervention: NRTI-containing regimen (PI/r + two NRTIs or NNRTI + two NRTIs)
Number of subjects: 117
Study 16510640 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary antibiotic prophylaxis
Number of subjects: 236
Study 16510640 — intervention group
Group type: COMPARATOR
Intervention: No urinary antibiotic prophylaxis (Control)
Number of subjects: 236
Study 15510485 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical mitomycin C (MMC) during trabeculectomy
Number of subjects: 0
Study 15510485 — intervention group
Group type: COMPARATOR
Intervention: Control group (no MMC)
Number of subjects: 0
Study 11022835 — intervention group
Group type: EXPERIMENTAL
Intervention: Pinaverlum bromide (50 mg, t.i.d.)
Number of subjects: 91
Study 11022835 — intervention group
Group type: EXPERIMENTAL
Intervention: Mebeverine (100 mg, t.i.d.)
Number of subjects: 91
Study 9486028 — intervention group
Group type: EXPERIMENTAL
Intervention: latanoprost 0.005% once daily for 4 weeks
Number of subjects: 24
Study 9486028 — intervention group
Group type: EXPERIMENTAL
Intervention: latanoprost 0.001% once daily for 4 weeks
Number of subjects: 24
Study 9486028 — intervention group
Group type: COMPARATOR
Intervention: Comparison of latanoprost 0.005% and 0.001%
Number of subjects: 24
Study 8354723 — intervention group
Group type: EXPERIMENTAL
Intervention: Flosser
Number of subjects: 35
Study 8354723 — intervention group
Group type: COMPARATOR
Intervention: Finger flossing
Number of subjects: 35
Study 3551827 — intervention group
Group type: EXPERIMENTAL
Intervention: Praziquantel at a dose of 75 mg/kg per day
Number of subjects: 74
Study 3551827 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study 3551827 — intervention group
Group type: EXPERIMENTAL
Intervention: Praziquantel
Number of subjects: 74
Study 31526286 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline 200 mg daily
Number of subjects: 36
Study 31526286 — intervention group
Group type: COMPARATOR
Intervention: PUVA (3 weekly sessions)
Number of subjects: 36
Study 31591018 — intervention group
Group type: EXPERIMENTAL
Intervention: Perineural dexamethasone 4 mg
Number of subjects: 182
Study 31591018 — intervention group
Group type: COMPARATOR
Intervention: Intravenous (i.v.) dexamethasone 4 mg
Number of subjects: 182
Study 29150377 — intervention group
Group type: EXPERIMENTAL
Intervention: Urgent ART (within 48 hours)
Number of subjects: 191
Study 29150377 — intervention group
Group type: COMPARATOR
Intervention: Post-stabilisation ART (in 7-14 days)
Number of subjects: 191
Study 29150377 — intervention group
Group type: EXPERIMENTAL
Intervention: Urgent ART
Number of subjects: 191
Study 29150377 — intervention group
Group type: COMPARATOR
Intervention: Post-stabilisation ART
Number of subjects: 191
Study 27056882 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower peak LA strain
Number of subjects: 357
Study 25066385 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylazine administered intravenously (i.v.)
Number of subjects: 6
Study 25066385 — intervention group
Group type: COMPARATOR
Intervention: Xylazine administered intra-osseously (IO)
Number of subjects: 6
Study 22310097 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted (RO) pedicle screw implantation
Number of subjects: 60
Study 22310097 — intervention group
Group type: COMPARATOR
Intervention: Freehand (FH) conventional technique
Number of subjects: 60
Study 20224274 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet, energy-restricted by 30% from estimated energy expenditure (approximately 600 kcal/day) for 8 weeks
Number of subjects: 114
Study 18343265 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone furoate (FF) nasal spray (110 microg)
Number of subjects: 127
Study 18343265 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone propionate (FP) nasal spray (200 microg)
Number of subjects: 127
Study 16889545 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise and dietary counseling (ExD)
Number of subjects: 151
Study 16889545 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 151
Study 16889545 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherers (Adh) to the intervention
Number of subjects: 151
Study 16889545 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonadherers (Nadh) to the intervention
Number of subjects: 151
Study 14671201 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 microg melatonin infused i.v.
Number of subjects: 10
Study 14671201 — intervention group
Group type: COMPARATOR
Intervention: Saline infused as the matching placebo
Number of subjects: 10
Study 10968843 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic Doppler ultrasound (US) assessment of ulcers
Number of subjects: 52
Study 10968843 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic therapy
Number of subjects: 52
Study 9053821 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal cord stimulation (SCS)
Number of subjects: 35
Study 1594227 — intervention group
Group type: EXPERIMENTAL
Intervention: Phototherapeutic keratectomy (27 eyes)
Number of subjects: 31
Study 1594227 — intervention group
Group type: COMPARATOR
Intervention: Photorefractive keratectomy (4 eyes)
Number of subjects: 31
Study 6375490 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month regimen (isoniazid and rifampicin throughout, with ethambutol and pyrazinamide for the initial 2-month intensive phase)
Number of subjects: 601
Study 6375490 — intervention group
Group type: COMPARATOR
Intervention: 12-month regimen (isoniazid and ethambutol throughout, supplemented by streptomycin during the first month)
Number of subjects: 601
Study 6375490 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month regimen (for patients with isoniazid-resistant strains)
Number of subjects: 601
Study 6375490 — intervention group
Group type: COMPARATOR
Intervention: 12-month regimen (for patients with isoniazid-resistant strains)
Number of subjects: 601
Study 29355046 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week hatha yoga intervention
Number of subjects: 40
Study 29355046 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 40
Study 27670577 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-course antibiotics (4 days)
Number of subjects: 0
Study 27670577 — intervention group
Group type: COMPARATOR
Intervention: Long-course antibiotics (duration not specified)
Number of subjects: 0
Study 25596054 — intervention group
Group type: EXPERIMENTAL
Intervention: Flutamide-combined androgen blockade therapy (F-CAB)
Number of subjects: 0
Study 25596054 — intervention group
Group type: COMPARATOR
Intervention: LH-RH monotherapy
Number of subjects: 0
Study 22652371 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg dl-α-tocopheryl acetate (VE1)
Number of subjects: 180
Study 22652371 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg dl-α-tocopheryl acetate (VE2)
Number of subjects: 180
Study 22652371 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg dl-α-tocopheryl acetate (VE3)
Number of subjects: 180
Study 22652371 — intervention group
Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 180
Study 20444744 — intervention group
Group type: EXPERIMENTAL
Intervention: PRO 2000 gel 0.5%
Number of subjects: 180
Study 20444744 — intervention group
Group type: EXPERIMENTAL
Intervention: PRO 2000 gel 2%
Number of subjects: 180
Study 20444744 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 180
Study 20444744 — intervention group
Group type: COMPARATOR
Intervention: Condom use only
Number of subjects: 180
Study 18517084 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone furoate, 110 microg once daily
Number of subjects: 100
Study 18517084 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 16096220 — intervention group
Group type: EXPERIMENTAL
Intervention: GRAIDS software intervention with trained lead clinician
Number of subjects: 45
Study 16096220 — intervention group
Group type: COMPARATOR
Intervention: Educational session and clinical guidelines for comparison practices
Number of subjects: 45
Study 11872282 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-daily thoracic radiation
Number of subjects: 0
Study 11872282 — intervention group
Group type: COMPARATOR
Intervention: Twice-daily thoracic radiation
Number of subjects: 0
Study 10442374 — intervention group
Group type: EXPERIMENTAL
Intervention: UFT plus cisplatin with concurrent radiotherapy
Number of subjects: 17
Study 8631075 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese herb-burn-incense
Number of subjects: 0
Study 8631075 — intervention group
Group type: COMPARATOR
Intervention: Routine air sterilization methods (ultraviolet radiator, formaldehyde, lactiacid method)
Number of subjects: 0
Study 2185625 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 g glucose
Number of subjects: 20
Study 2185625 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.9 g uncooked cornstarch
Number of subjects: 20
Study 2185625 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 g glucose followed 20 min later by 1.75 g fructose
Number of subjects: 20
Study 2185625 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.9 g uncooked cornstarch followed 20 min later by 1.75 g fructose
Number of subjects: 20
Study 2185625 — intervention group
Group type: EXPERIMENTAL
Intervention: Water followed 20 min later by 1.75 g fructose
Number of subjects: 20
Study 2185625 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary chromium excretion
Number of subjects: 20
Study 7396141 — intervention group
Group type: EXPERIMENTAL
Intervention: Droperidol 150 microgram/kg intravenously before anaesthesia
Number of subjects: 20
Study 7396141 — intervention group
Group type: COMPARATOR
Intervention: Control group (no droperidol)
Number of subjects: 20
Study 31712987 — intervention group
Group type: EXPERIMENTAL
Intervention: Early preventive measures including an early nephrology review applied to high risk patients
Number of subjects: 206
Study 31712987 — intervention group
Group type: COMPARATOR
Intervention: Observation arm (no early preventive measures)
Number of subjects: 206
Study 31142519 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical manipulation
Number of subjects: 20
Study 31142519 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal neck rotation
Number of subjects: 20
Study 31142519 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical manipulation and maximal neck rotation
Number of subjects: 20
Study 31142519 — intervention group
Group type: COMPARATOR
Intervention: Neutral neck position
Number of subjects: 20
Study 27918927 — intervention group
Group type: EXPERIMENTAL
Intervention: Meatballs with 3% and 6% dietary fibre from rye bran
Number of subjects: 27
Study 27918927 — intervention group
Group type: EXPERIMENTAL
Intervention: Meatballs with 3% and 6% dietary fibre from pea fibre
Number of subjects: 27
Study 27918927 — intervention group
Group type: COMPARATOR
Intervention: Control (meatballs without added fibre)
Number of subjects: 27
Study 25921600 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin (150 mg, theracurmin)
Number of subjects: 14
Study 25921600 — intervention group
Group type: COMPARATOR
Intervention: Placebo (starch)
Number of subjects: 14
Study 23358161 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG hydrogel dural sealant capping
Number of subjects: 10
Study 23358161 — intervention group
Group type: COMPARATOR
Intervention: No intervention (Control Group A)
Number of subjects: 10
Study 21294635 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Online Self-helping Center (HOSC) in laboratory environment
Number of subjects: 65
Study 21294635 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Online Self-helping Center (HOSC) in natural environment
Number of subjects: 65
Study 21294635 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninteractive program
Number of subjects: 65
Study 21294635 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 65